There is overwhelming evidence that thrombolytic therapy reduces mortality and morbidity in patients presenting with ST segment elevation or new left bundle branch block myocardial infarction (STEMI).These benefits are greatest when thrombolysis is given at the earliest opportunity after symptom onset.